Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Setting
2.2. Vaccinations
2.3. Laboratory Tests
2.4. Data Analysis
3. Results
3.1. Retrospective Case Series
3.2. Necessity of Booster Vaccination
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Lewis, J.D.; Enfield, K.B.; Sifri, C.D. Hepatitis B in healthcare workers: Transmission events and guidance for management. World J. Hepatol. 2015, 7, 488–497. [Google Scholar] [CrossRef] [PubMed]
- Ryan, K.J.; Ray, C.G.; Sherris, J.C. Sherris Medical Microbiology; McGraw-Hill Medical: New York, NY, USA, 2010. [Google Scholar]
- European Centre for Disease Prevention and Control. Monitoring the Responses to Hepatitis B and C Epidemics in EU/EEA Member States, 2019; ECDC: Stockholm, Sweden, 2020. [Google Scholar]
- WHO. Hepatitis B. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (accessed on 6 January 2021).
- European Centre for Disease Prevention and Control. Hepatitis B ECDC Annual Epidemiological Report for 2017; ECDC: Stockholm, Sweden, 2019. [Google Scholar]
- De Schryver, A.; Claesen, B.; Meheus, A.; van Sprundel, M.; François, G. European survey of hepatitis B vaccination policies for healthcare workers. Eur. J. Public Health 2010, 21, 338–343. [Google Scholar]
- WHO. Hepatitis B vaccines: WHO position paper, July 2017—Recommendations. Vaccine 2019, 37, 223–225. [Google Scholar] [CrossRef] [PubMed]
- Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000, 355, 561–565. [CrossRef]
- Rijksinstituut voor Volksgezondheid en Milieu. Richtlijn Uitvoering RVP. 2020. Available online: https://rijksvaccinatieprogramma.nl/professionals/richtlijnen/rvp-richtlijn-uitvoering (accessed on 7 December 2020).
- RIVM-LCI. Praktijkrichtlijn voor Bedrijfsartsen: Hepatitis B-Vaccinatie van Risicolopend Personeel Dat Geen Risicovormer Is. 2016. Available online: https://lci.rivm.nl/sites/default/files/2019-06/Praktijkrichtlijn%20voor%20bedrijfsartsen%20hepatitis%20B-vaccinatie%20van%20risicolopend%20personeel.pdf (accessed on 7 December 2020).
- Leuridan, E.; Van Damme, P. Hepatitis B and the Need for a Booster Dose. Clin. Infect. Dis. 2011, 53, 68–75. [Google Scholar] [CrossRef] [PubMed]
- Yang, S.; Tian, G.; Cui, Y.; Ding, C.; Deng, M.; Yu, C.; Xu, K.; Ren, J.; Yao, J.; Li, Y.; et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci. Rep. 2016, 6, 27251. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Authority HPR. Human Vaccines. Available online: http://www.hpra.ie/homepage/medicines/medicines-information/vaccines (accessed on 18 December 2020).
- Bini, C.; Grazzini, M.; Chellini, M.; Mucci, N.; Arcangeli, G.; Tiscione, E.; Bonanni, P. Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy. Hum. Vaccines Immunother. 2017, 14, 450–455. [Google Scholar] [CrossRef] [PubMed]
- Grosso, G.; Mistretta, A.; Marventano, S.; Ferranti, R.; Mauro, L.; Cunsolo, R.; Proietti, L.; Malaguarnera, M. Long-Term Persistence of Seroprotection by Hepatitis B Vaccination in Healthcare Workers of Southern Italy. Zahedan J. Res. Med. Sci. 2012, 12, e6025. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lamberti, M.; De Rosa, A.; Garzillo, E.M.; Corvino, A.R.; Sannolo, N.; De Pascalis, S.; Di Fiore, E.; Westermann, C.; Arnese, A.; Gabriella, D.G.; et al. Vaccination against hepatitis b virus: Are Italian medical students sufficiently protected after the public vaccination programme? J. Occup. Med. Toxicol. 2015, 10, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Verso, M.G.; Costantino, C.; Vitale, F.; Amodio, E. Immunization against Hepatitis B Surface Antigen (HBsAg) in a Cohort of Nursing Students Two Decades after Vaccination: Surprising Feedback. Vaccines 2019, 8, 1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bagheri-Jamebozorgi, M.; Keshavarz, J.; Nemati, M.; Mohammadi-Hossainabad, S.; Rezayati, M.-T.; Nejad-Ghaderi, M.; Jamalizadeh, A.; Shokri, F.; Jafarzadeh, A. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum. Vaccines Immunother. 2014, 10, 3731–3736. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saffar, H.; Saffar, M.J.; Ajami, A.; Khalilian, A.R.; Shams-Esfandabad, K.; Mirabi, A.M. Long-Term T-Cell-Mediated Immunologic Memory to Hepatitis B Vaccine in Young Adults Following Neonatal Vaccination. Zahedan J. Res. Med. Sci. 2014, 14, e22223. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bauer, T.; Jilg, W. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 2006, 24, 572–577. [Google Scholar] [CrossRef] [PubMed]
- Wang, R.X.; Boland, G.J.; van Hattum, J.; de Gast, G.C. Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination. World J. Gastroenterol. 2004, 10, 260–263. [Google Scholar] [CrossRef] [PubMed]
- Carollo, M.; Palazzo, R.; Bianco, M.; Pandolfi, E.; Chionne, P.; Fedele, G.; Tozzi, A.E.; Carsetti, R.; Romanò, L.; Ausiello, C.M. Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level. Vaccine 2013, 31, 506–513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Immunization Action Coalition. Hepatitis B and the Health Care Worker: CDC. Available online: https://www.who.int/occupational_health/activities/3hepatiti.pdf (accessed on 7 December 2020).
- ECDC. Vaccine Schedules in all Countries of the European Union: European Centre for Disease Prevention and Control. 2020. Available online: https://vaccine-schedule.ecdc.europa.eu/ (accessed on 18 December 2020).
Titre ≤ 10 IU/L (n = 16) | Titre > 10 IU/L (n = 64) | Sign. | |
---|---|---|---|
Age, years (SD) | 18.5 (1.2) | 18.4 (0.8) | 0.960 b |
Female (%) | 12 (75) | 47 (73) | 0.899 a |
Months since last HBV vaccination (SD) | 122 (64) | 79 (60) | 0.018 b |
Vaccination scheme | |||
Ambirix® (%) | 8 (50) | 37 (58) | 0.067 a |
Twinrix® (%) | 1 (6) | 8 (13) | |
Engerix® (%) | 5 (31) | 7 (11) | |
Unknown (%) | 2 (13) | 12 (19) |
Scenario | Appointment | 1 | 2 | 3 | Total | Mean nr. of Appointments Per Student |
---|---|---|---|---|---|---|
A | Booster vaccination | 80 | 0 | - | 160 | 2 |
Titre determination | 0 | 80 | - | |||
B | Booster vaccination | 0 | 16 | - | 112 | 1.4 |
Titre determination | 80 | 0 | 16 | |||
C | Booster vaccination | 49 | 2 | - | 133 | 1.7 |
Titre determination | 31 | 49 | 2 | |||
D | Booster vaccination | 23 | 8 | - | 119 | 1.5 |
Titre determination | 57 | 23 | 8 | |||
E | Booster vaccination | 8 | 12 | - | 112 | 1.4 |
Titre determination | 72 | 8 | 12 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
van Leeuwen, L.P.M.; Doornekamp, L.; Goeijenbier, S.; de Jong, W.; de Jager, H.J.; van Gorp, E.C.M.; Goeijenbier, M. Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital. Vaccines 2021, 9, 69. https://doi.org/10.3390/vaccines9020069
van Leeuwen LPM, Doornekamp L, Goeijenbier S, de Jong W, de Jager HJ, van Gorp ECM, Goeijenbier M. Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital. Vaccines. 2021; 9(2):69. https://doi.org/10.3390/vaccines9020069
Chicago/Turabian Stylevan Leeuwen, Leanne P. M., Laura Doornekamp, Simone Goeijenbier, Wesley de Jong, Herbert J. de Jager, Eric C. M. van Gorp, and Marco Goeijenbier. 2021. "Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital" Vaccines 9, no. 2: 69. https://doi.org/10.3390/vaccines9020069
APA Stylevan Leeuwen, L. P. M., Doornekamp, L., Goeijenbier, S., de Jong, W., de Jager, H. J., van Gorp, E. C. M., & Goeijenbier, M. (2021). Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital. Vaccines, 9(2), 69. https://doi.org/10.3390/vaccines9020069